Glutathione depletion in tissues after administration of buthionine sulphoximine
- PMID: 6469748
- DOI: 10.1016/0360-3016(84)90329-8
Glutathione depletion in tissues after administration of buthionine sulphoximine
Abstract
Buthionine sulphoximine (BSO) an inhibitor of glutathione (GSH) biosynthesis, was administered to mice in single and repeated doses of 0.5, 1 and 5 mmol kg-1 (i.p.). The resultant pattern of GSH depletion was studied in liver, kidney, skeletal muscle and three types of murine tumor. Liver and kidney exhibited a rapid depletion to GSH levels of ca. 20% of controls after single doses of 1-5 mmol kg-1 BSO. Muscle was depleted to a similar level, but at a slower rate after a single dose. All three tumors required repeated administration of BSO over several days to obtain a similar degree of depletion to that shown in the other tissues.
Similar articles
-
Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.J Natl Cancer Inst. 1987 Oct;79(4):811-5. J Natl Cancer Inst. 1987. PMID: 3477662
-
Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.Br J Cancer. 1987 Jul;56(1):33-8. doi: 10.1038/bjc.1987.148. Br J Cancer. 1987. PMID: 3620316 Free PMC article.
-
Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.Toxicol Appl Pharmacol. 1991 Feb;107(2):269-84. doi: 10.1016/0041-008x(91)90208-v. Toxicol Appl Pharmacol. 1991. PMID: 1994510
-
Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.Biochem J. 1993 Jun 1;292 ( Pt 2)(Pt 2):477-83. doi: 10.1042/bj2920477. Biochem J. 1993. PMID: 8503882 Free PMC article.
-
Glutathione metabolism.Methods Enzymol. 1995;251:3-7. doi: 10.1016/0076-6879(95)51106-7. Methods Enzymol. 1995. PMID: 7651209 Review. No abstract available.
Cited by
-
Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium.Transl Oncol. 2012 Jun;5(3):190-9. doi: 10.1593/tlo.11322. Epub 2012 Jun 1. Transl Oncol. 2012. PMID: 22741038 Free PMC article.
-
In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.Br J Cancer. 1993 Dec;68(6):1071-9. doi: 10.1038/bjc.1993.484. Br J Cancer. 1993. PMID: 8260357 Free PMC article.
-
Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.Br J Cancer. 1986 Nov;54(5):749-54. doi: 10.1038/bjc.1986.236. Br J Cancer. 1986. PMID: 3801271 Free PMC article.
-
Modifiers of radiosensitivity.Experientia. 1989 Jan 15;45(1):41-52. doi: 10.1007/BF01990451. Experientia. 1989. PMID: 2643526 Review. No abstract available.
-
Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester.Proc Natl Acad Sci U S A. 1989 Jan;86(2):471-5. doi: 10.1073/pnas.86.2.471. Proc Natl Acad Sci U S A. 1989. PMID: 2911592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources